Radical prostatectomy is still the most widely recommended treatment for prostate cancer. Yet, according to a recent study, only one out of every forty-eight men who undergo this debilitating procedure survives longer than those who forgo surgery. Invasion of the Prostate Snatchers reports the latest thinking on prostate cancer management in clear, easy-to-understand prose. In a unique collaboration, a patient and his doctor provide a new perspective on living with this disease. Ralph Blum’s surprisingly entertaining twenty-year journey and eventual decision to treat his cancer as a “chronic condition,” together with Dr. Mark Scholz’s presentation of the newest scientific evidence, will liberate thousands of newly diagnosed men to pursue a noninvasive approach and thereby preserve normal sexual and urinary function.
“Invasion of the Prostate Snatchers is a must read for anyone who wants to get a glimpse of what the practice of future medicine needs to be. Dr. Scholz cares not only about the scientific and clinical evidence but also, very deeply and very personally, about his many patients. We need professionals like Scholz if ever we are to move forward in our current health care programs.”
– T. Colin Campbell, PhD, Jacob Gould Schurman Professor Emeritus of Nutritional Biochemistry, Cornell University, and co-author of The China Study
“A provocative and frank look at the bewildering world of prostate cancer, from the current state of the multibillion-dollar industry to the range of available treatments…prostate cancer is a dark and mysterious country, and Mr. Blum and Dr. Scholz are good, levelheaded guides through these thickets. And in telling men to slow up and take a deep breath after they learn they have prostate cancer, they provide an invaluable service. I wish I had had this book back in 2008.”
– Dana Jennings, The New York Times
About the Book
Disclosure of Material Connection: Some of the links in the page above are "affiliate links." This means if you click on the link and purchase the item, I will receive an affiliate commission. I am disclosing this in accordance with the Federal Trade Commission's 16 CFR, Part 255: "Guides Concerning the Use of Endorsements and Testimonials in Advertising."